WallStreetZenWallStreetZen

NASDAQ: ALRN
Aileron Therapeutics Inc Earnings & Revenue

ALRN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.9M
Current Profit Margin
0%

ALRN Return on Equity

Current Company
-91%
Current Industry
15.4%
Current Market
-8.4%
ALRN's Return on Equity (-91%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ALRN announces earnings.

ALRN Return on Assets

Current Company
-78.5%
Current Industry
2.2%
ALRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALRN Return on Capital Employed

Current Company
-115.56%
Current Industry
17.7%
ALRN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ALRN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALRN$0.00-$12.83M-$12.94MN/AN/A
INKT$0.00-$22.25M-$22.46M-100.00%N/A
NTRB$2.09M-$4.92M-$5.28M+66.58%N/A
ACST$0.00-$48.89M-$38.77M-100.00%N/A
SPRB$10.09M-$47.14M-$47.92MN/AN/A

ALRN earnings dates

Next earnings date
May 6, 2024

Aileron Therapeutics Earnings & Revenue FAQ

What were ALRN's earnings last quarter?

On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q3 2023 earnings per share (EPS) of -$0.40, up 71.43% year over year. Total Aileron Therapeutics earnings for the quarter were -$1.83 million. In the same quarter last year, Aileron Therapeutics's earnings per share (EPS) was -$1.40.

If you're new to stock investing, here's how to buy Aileron Therapeutics stock.

What was ALRN's earnings growth in the past year?

As of Q1 2024, Aileron Therapeutics's earnings has grown year over year. Aileron Therapeutics's earnings in the past year totalled -$12.94 million.

What is ALRN's earnings date?

Aileron Therapeutics's earnings date is Invalid Date. Add ALRN to your watchlist to be reminded of ALRN's next earnings announcement.

What was ALRN's revenue last quarter?

On Invalid Date, Aileron Therapeutics (NASDAQ: ALRN) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aileron Therapeutics's revenue was $0.00.

What was ALRN's revenue growth in the past year?

As of Q1 2024, Aileron Therapeutics's revenue has grown null year over year. Aileron Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.